Trial Profile
A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants With Proliferating Infantile Hemangiomas (IHs) Requiring Systemic Therapy to Compare 4 Regimens of Propranolol (1 or 3 mg/kg/Day for 3 or 6 Months) to Placebo (Double Blind)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Sep 2016
Price :
$35
*
At a glance
- Drugs Propranolol (Primary)
- Indications Haemangioma
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 24 Feb 2015 New trial record
- 20 Feb 2015 According to a Pierre Fabre media release, the results of this trial were presented in New England Journal of Medicine.
- 20 Feb 2015 Results published in a Pierre Fabre media release.